Antipsychotic agents

Differentiating Aspects of Oral and Long-acting Injectable Antipsychotic Drugs for Tailoring the Therapy of Schizophrenia

Research from the University of Siena details new data on the advantages and disadvantages of oral and long-acting injectable antipsychotic medications for treating schizophrenia. The study, published in International Clinical Psychopharmacology, aimed to support clinicians in choosing the most suitable formulation based on clinical symptoms. Financial support for the research

Differentiating Aspects of Oral and Long-acting Injectable Antipsychotic Drugs for Tailoring the Therapy of Schizophrenia

Antipsychotic agents

Widespread Off-Label Use of Antidepressants and Antipsychotics in Children and Adolescents

Widespread off-label use of antidepressants and antipsychotics in children and adolescents has been a longstanding concern in the medical community. A recent study conducted at the University Hospital of Wuerzburg in Germany has shed light on the prevalence and factors associated with this practice. The study, published in the journal

Antipsychotic agents

Long-Acting Injectable Antipsychotics Hold Promise in Treating Schizophrenia

According to recent research from Italy, long-acting injectable antipsychotics (LAIs) have the potential to significantly impact treatment adherence and disease trajectories in patients with schizophrenia. However, their utilization in clinical practice remains limited. The study, conducted by Alessandra Massaro and colleagues, surveyed Italian psychiatrists to evaluate their attitudes towards LAIs

Antipsychotic agents

Dementia Patients in Hospice Care Face Higher Risk of Death with Benzodiazepine and Antipsychotic Use

A study published in JAMA Network Open reveals that patients with dementia in hospice care who start taking benzodiazepines or antipsychotics are more likely to die within six months than similar patients who do not receive these medications. The study analyzed national Medicare data from 2014 to 2018 and found

Antidepressants

Therapeutic Reference Ranges for Psychotropic Drugs in Children and Adolescents

Research has been conducted to determine serum concentrations of selective serotonin reuptake inhibitors (SSRIs) and atypical antipsychotics in children and adolescents. The study, led by Xenia M. Hart, aimed to provide guidance for the definition of therapeutic reference ranges in this age group. The researchers collected serum concentrations of various